Tamoxifen is a popular medication that may help reduce the risk of certain types of breast cancer by interfering with estrogen activity, which can promote tumor growth. Although there are several side effects that may cause problems (blood clots and cancer of the uterus, for example), it’s been found that tamoxifen’s benefits tend to outweigh the risks. (National Cancer Institute )
However, we know that people don’t get sick in a vacuum. Many women (and men) who have breast cancer may be ill with other diseases or disorders, which means they may be taking other medications that could end up interacting …read more

Two announcements, one today and one last week, tell us of new drug indication approvals for medications used to treat depression.
Symbyax (olanzapine and fluoxetine HCl capsules) manufactured by Eli Lilly and Company was originally approved for treatment of bipolar depression. It’s now approved for acute treatment of treatment-resistant depression. This means if you’ve been treated with other medications for your depression without success, this medication may be tried and may work for you. It gives doctors another tool.
The FDA has also approved a change in indication for Lexapro (escitalopram oxalate ) for the acute and maintenance treatment …read more